Antigua and Barbuda vs Iran, Islamic Republic of: Pancreatic cancer death rate
Antigua and Barbuda
3.14 deaths per 100,000 people
in 2021
Iran, Islamic Republic of
3.44 deaths per 100,000 people
in 2017
Antigua and Barbuda rank
83rd
Iran, Islamic Republic of rank
81st
Pancreatic cancer death rate over time
- Antigua and Barbuda
- Iran, Islamic Republic of
How they compare
Iran, Islamic Republic of currently reports 3.44 deaths per 100,000 people against 3.14 deaths per 100,000 people in Antigua and Barbuda, a difference of 0.3 deaths per 100,000 people.
That makes Iran, Islamic Republic of's figure about 1.1 times Antigua and Barbuda's.
The two have swapped places 1 time across 5 shared years of data; in 2013 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 83rd and Iran, Islamic Republic of ranks 81st of 111 countries.
Antigua and Barbuda has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher pancreatic cancer death rate, Antigua and Barbuda or Iran, Islamic Republic of?
- Iran, Islamic Republic of, at 3.44 deaths per 100,000 people against 3.14 deaths per 100,000 people in Antigua and Barbuda as of 2017.
- What is the difference in pancreatic cancer death rate between Antigua and Barbuda and Iran, Islamic Republic of?
- 0.3 deaths per 100,000 people, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Antigua and Barbuda and Iran, Islamic Republic of?
- 5 years are reported by both, from 2013 to 2017.
- How do Antigua and Barbuda and Iran, Islamic Republic of rank globally for pancreatic cancer death rate?
- Antigua and Barbuda ranks 83rd and Iran, Islamic Republic of ranks 81st of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Pancreatic cancer death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from pancreas cancer in both sexes in those aged all ages per 100,000 people.